Theralase is one step away from the Phase I / II human clinical trials
Click download link to listen on this device: Download Show
Patience Sam..TLT will eventually earn her ticket. We are witnessing an investors temper tantrum..nothing more. Why is everyone so bent about warrants? The 5 yr term? …they will likely be churned up this year. and they wont be in the money till $0.55. Short term traders lost a little power..nothing more. GLTA
This is not a question “will this work in humans” It already works in humans. There are already over a hundred clinics around the world doing this every day. PDT (photodynamic therapy) is used sucessfully as a cancer treatment in Russia, China, UK, USA, SA. etc but Its use is limited to simple superficial applications. Currently others define success as a 30-50% tumor reduction, (occasionally !00%) but the results are sporatic because they lack the ability to adequately control the treatment protocol. Inferior compounds, controls, targeting, photobleaching problems which deminish efficacy. toxicity side effects , PDCs which only respond to a narrow frequecy band dramatically limit their use, etc.
Theralase is assembling advanced tehniques …PDCs which repond a wide range of frequencies including infrared light (for deeper and larger tumors) so the treatment can be tailored to specific needs,low photobleaching, low toxicity, superior light sensors, superior cancer cell targeting, the computing power to control and monitor the treatments progress in real time, in a nutshell…treatment protocols which will preform with more consistant and dependable results. The how and why is in the details.
Theralse will first challenge bladder cancer, then these technologies will challenge other types of cancer because they are versitile. The cancer targeting of Rutherrin..many types of cancer have tranferrin sites . The compounds are proven (in a petri dish) to kill 100% of aprox 10 types of cancer cells. The light probes measure light penetration in various tissues, but they are under development…and they will be patented by Dr Lilge et al Toxicity is now being studied in detail, but the preliminary findings show a green light (pun intended) Much of this work is complete, some is under development. God speed.
As for advice to the current investors panic and infantile impatient temper tantrum…no comment. GLTA Aubrey
after last Mondays interview with TLT’s ceo roger white, there was a comment made about assisting TLT in moving to a major exchange. I was wondering if you could comment further . I am a big fan of TLT and market change is due. thanks